Back to Journals » OncoTargets and Therapy » Volume 16

MLPH Accelerates the Epithelial–Mesenchymal Transition in Prostate Cancer [Retraction]

Authors Zhang T, Sun Y, Zheng T, Wang R, Jia D, Zhang W

Received 14 December 2023

Accepted for publication 14 December 2023

Published 15 December 2023 Volume 2023:16 Pages 1051—1052

DOI https://doi.org/10.2147/OTT.S454940



Zhang T, Sun Y, Zheng T, Wang R, Jia D, Zhang W. Onco Targets Ther. 2020;13:701-708.

We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article.

Following publication of the article, concerns were raised about the duplication of images from Figure 3 with images from other unrelated articles. Specifically,

  • The image for Figure 3A, PC3, sh1 has been duplicated with the image for Figure 8A, Ctrl+siNC from Wang D, Chen J, Ding Y, et al. RETRACTED ARTICLE: miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia. Onco Targets Ther. 2020;13:6681-6697. https://doi.org/10.2147/OTT.S244813.

The authors did not respond to our queries and were unable to provide an explanation for the duplicated images or provide data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.